Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts


  Free Subscription


3 Am J Hematol
1 Biochem Biophys Res Commun
3 Blood
1 Bone Marrow Transplant
3 Cancer
2 Cancer Res
1 Cell
2 Eur J Haematol
1 Exp Cell Res
2 Int J Hematol
1 J Clin Oncol
3 J Pediatr Hematol Oncol
1 Leuk Lymphoma
2 Leuk Res
10 Leukemia
1 N Engl J Med

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Hematol

  1. DECROOCQ J, Itzykson R, Vigouroux S, Michallet M, et al
    Similar outcome of allogeneic stem cell transplantation after myeloablative and sequential conditioning regimen in patients with refractory or relapsed acute myeloid leukemia: A study from the Societe Francophone de Greffe de Moelle et de Therapie Cel
    Am J Hematol. 2017 Dec 11. doi: 10.1002/ajh.25004.
    PubMed     Text format     Abstract available

  2. BAIN BJ
    Pure erythroid leukemia.
    Am J Hematol. 2017 Dec 11. doi: 10.1002/ajh.25005.
    PubMed     Text format    

  3. BEHRENS M, Chowdry RP, Saba S, Saba NS, et al
    A centrocyte blood count of a quarter million.
    Am J Hematol. 2017;92:972-973.
    PubMed     Text format    

    Biochem Biophys Res Commun

  4. HE MH, Zhang Q, Shu G, Lin JC, et al
    Dihydromyricetin sensitizes human acute myeloid leukemia cells to retinoic acid-induced myeloid differentiation by activating STAT1.
    Biochem Biophys Res Commun. 2017 Dec 7. pii: S0006-291X(17)32415.
    PubMed     Text format     Abstract available


  5. YAO L, Wen L, Wang N, Liu T, et al
    Identification of novel recurrent STAT3-RARA fusions in acute promyelocytic leukemia lacking t(15;17)(q22;q12)/PML-RARA.
    Blood. 2017 Dec 13. pii: blood-2017-09-807370. doi: 10.1182/blood-2017-09-807370
    PubMed     Text format    

  6. RAIKAR SS, Park SI, Leong T, Jaye DL, et al
    Isolated myeloperoxidase expression in pediatric B/myeloid mixed phenotype acute leukemia is linked with better survival.
    Blood. 2017 Dec 9. pii: blood-2017-09-807602. doi: 10.1182/blood-2017-09-807602.
    PubMed     Text format    

    FCR achieves long-term durable remissions in patients with IGHV-mutated CLL.
    Blood. 2017;130:2278-2282.
    PubMed     Text format     Abstract available

    Bone Marrow Transplant

  8. FERGUSON P, Craddock C
    Allogeneic transplantation in primary refractory AML.
    Bone Marrow Transplant. 2017;52:950-951.
    PubMed     Text format    


  9. ABAZA YM, Kadia TM, Jabbour EJ, Konopleva MY, et al
    Phase 1 dose escalation multicenter trial of pracinostat alone and in combination with azacitidine in patients with advanced hematologic malignancies.
    Cancer. 2017;123:4851-4859.
    PubMed     Text format     Abstract available

  10. MARRIOTT CJC, Beaumont LF, Farncombe TH, Cranston AN, et al
    Body composition in long-term survivors of acute lymphoblastic leukemia diagnosed in childhood and adolescence: A focus on sarcopenic obesity.
    Cancer. 2017 Dec 12. doi: 10.1002/cncr.31191.
    PubMed     Text format     Abstract available

  11. ROSENSTOCK AS, Niu J, Giordano SH, Zhao H, et al
    Acute myeloid leukemia and myelodysplastic syndrome after adjuvant chemotherapy: A population-based study among older breast cancer patients.
    Cancer. 2017 Dec 13. doi: 10.1002/cncr.31144.
    PubMed     Text format     Abstract available

    Cancer Res

  12. DE DOMINICI M, Porazzi P, Soliera AR, Mariani SA, et al
    Targeting CDK6 and BCL2 exploits the "MYB addiction" of Ph+ acute lymphoblastic leukemia.
    Cancer Res. 2017 Dec 12. pii: 0008-5472.CAN-17-2644.
    PubMed     Text format     Abstract available

  13. NOBREGA-PEREIRA S, Caiado F, Carvalho T, Matias I, et al
    VEGFR-2-mediated reprogramming of mitochondrial metabolism regulates the sensitivity of acute myeloid leukemia to chemotherapy.
    Cancer Res. 2017 Dec 11. pii: 0008-5472.CAN-17-1166.
    PubMed     Text format     Abstract available


  14. RASKO JEJ, Hughes TP
    First Approved Kinase Inhibitor for AML.
    Cell. 2017;171:981.
    PubMed     Text format     Abstract available

    Eur J Haematol

  15. JAMROZIAK K, Szymczyk A, Hus M, Wojciechowska M, et al
    Hodgkin's variant of Richter's transformation during ibrutinib therapy in a series of CLL patients; the Polish Adult Leukemia Group report (PALG).
    Eur J Haematol. 2017 Dec 15. doi: 10.1111/ejh.13016.
    PubMed     Text format     Abstract available

  16. GONG X, Lin D, Wang H, Wang Y, et al
    Flow Cytometric Analysis of Cerebrospinal Fluid in Adult Patients with Acute Lymphoblastic Leukemia during Follow-Up.
    Eur J Haematol. 2017 Dec 14. doi: 10.1111/ejh.13011.
    PubMed     Text format     Abstract available

    Exp Cell Res

  17. MIN QH, Wang XZ, Zhang J, Chen QG, et al
    Exosomes derived from imatinib-resistant chronic myeloid leukemia cells mediate a horizontal transfer of drug-resistant trait by delivering miR-365.
    Exp Cell Res. 2017 Dec 6. pii: S0014-4827(17)30643.
    PubMed     Text format     Abstract available

    Int J Hematol

  18. SUZUKI D, Kobayashi R, Sano H, Hori D, et al
    Sarcopenia after induction therapy in childhood acute lymphoblastic leukemia: its clinical significance.
    Int J Hematol. 2017 Dec 12. pii: 10.1007/s12185-017-2388.
    PubMed     Text format     Abstract available

  19. MIYAMOTO T, Nagafuji K, Fujisaki T, Uchida N, et al
    Prospective randomization of post-remission therapy comparing autologous peripheral blood stem cell transplantation versus high-dose cytarabine consolidation for acute myelogenous leukemia in first remission.
    Int J Hematol. 2017 Dec 14. pii: 10.1007/s12185-017-2389.
    PubMed     Text format     Abstract available

    J Clin Oncol

    How Does One Decide Which Tyrosine Kinase Inhibitor To Use for the Initial Treatment of Chronic-Phase Chronic Myeloid Leukemia?
    J Clin Oncol. 2017;35:567.
    PubMed     Text format    

    J Pediatr Hematol Oncol

  21. NAKAGAWA S, Okamoto Y, Kodama Y, Nishikawa T, et al
    Thiamylal Plus Pentazocine Shows Similar Efficacy as Ketamine Plus Midazolam for Painful Procedures in Children With Leukemia.
    J Pediatr Hematol Oncol. 2017 Dec 12. doi: 10.1097/MPH.0000000000001053.
    PubMed     Text format     Abstract available

  22. LIU AP, Leung AW, Cheuk DK, Lee V, et al
    Gemtuzumab Ozogamicin Containing Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia (AML) in Children.
    J Pediatr Hematol Oncol. 2017 Dec 12. doi: 10.1097/MPH.0000000000001010.
    PubMed     Text format    

  23. KOUZUKI K, Umeda K, Saida S, Kato I, et al
    Sudden Intracranial Hemorrhage in a Patient With Atypical Chronic Myeloid Leukemia in Chronic Phase.
    J Pediatr Hematol Oncol. 2017 Dec 8. doi: 10.1097/MPH.0000000000001061.
    PubMed     Text format     Abstract available

    Leuk Lymphoma

  24. XVII International Workshop on Chronic Lymphocytic Leukemia 2017 May 12--15, 2017, New York.
    Leuk Lymphoma. 2017;58.
    PubMed     Text format    

    Leuk Res

  25. ZHU HH, Guo ZP, Jia JS, Jiang Q, et al
    The impact of oral arsenic and all-trans-retinoic acid on coagulopathy in acute promyelocytic leukemia.
    Leuk Res. 2017;65:14-19.
    PubMed     Text format     Abstract available

  26. CULL AH, Mahendru D, Snetsinger B, Good D, et al
    Overexpression of Arginase 1 is linked to DNMT3A and TET2 mutations in lower-grade myelodysplastic syndromes and chronic myelomonocytic leukemia.
    Leuk Res. 2017;65:5-13.
    PubMed     Text format     Abstract available


  27. GARCIA-MANERO G, Sekeres MA, Egyed M, Breccia M, et al
    A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with 30% blasts.
    Leukemia. 2017;31:2799-2806.
    PubMed     Text format     Abstract available

  28. CASADO P, Wilkes EH, Miraki-Moud F, Hadi MM, et al
    Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells.
    Leukemia. 2017 Dec 12. pii: leu2017349. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available

  29. YOKOTA A, Hirai H, Shoji T, Maekawa T, et al
    Constitutively active ABL family kinases, TEL/ABL and TEL/ARG, harbor distinct leukemogenic activities in vivo.
    Leukemia. 2017;31:2742-2751.
    PubMed     Text format     Abstract available

  30. LYU Y, Lou J, Yang Y, Feng J, et al
    Dysfunction of the WT1-MEG3 signaling promotes AML leukemogenesis via p53-dependent and -independent pathways.
    Leukemia. 2017;31:2543-2551.
    PubMed     Text format     Abstract available

  31. ZHANG H, Reister Schultz A, Luty S, Rofelty A, et al
    Characterization of the leukemogenic potential of distal cytoplasmic CSF3R truncation and missense mutations.
    Leukemia. 2017;31:2752-2760.
    PubMed     Text format     Abstract available

  32. RASCHE M, von Neuhoff C, Dworzak M, Bourquin JP, et al
    Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004.
    Leukemia. 2017;31:2807-2814.
    PubMed     Text format     Abstract available

  33. DELGADO-MARTIN C, Meyer LK, Huang BJ, Shimano KA, et al
    JAK/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias.
    Leukemia. 2017;31:2568-2576.
    PubMed     Text format     Abstract available

  34. ELDER A, Bomken S, Wilson I, Blair HJ, et al
    Abundant and equipotent founder cells establish and maintain acute lymphoblastic leukaemia.
    Leukemia. 2017;31:2577-2586.
    PubMed     Text format     Abstract available

  35. GRZES KM, Swamy M, Hukelmann JL, Emslie E, et al
    Control of amino acid transport coordinates metabolic reprogramming in T-cell malignancy.
    Leukemia. 2017;31:2771-2779.
    PubMed     Text format     Abstract available

  36. TESIO M, Trinquand A, Ballerini P, Hypolite G, et al
    Age-related clinical and biological features of PTEN abnormalities in T-cell acute lymphoblastic leukaemia.
    Leukemia. 2017;31:2594-2600.
    PubMed     Text format     Abstract available

    N Engl J Med

  37. KORTE AKM, Vos JM
    Ecthyma Gangrenosum.
    N Engl J Med. 2017;377:e32.
    PubMed     Text format    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.